Multiturn Conversations and Prompts for Neurodegenerative

Data Characteristics

Quality documents in the neurodegenerative disease field come from diverse sources. These include clinical trial reports, Good Manufacturing Practice (GMP) documents, New Drug Application (NDA)/Biologics License Application (BLA) materials, batch production records, Standard Operating Procedures (SOPs) for testing, and regulatory updates. Update frequencies vary. Regulatory documents may update annually or quarterly. Batch production records generate in real time. Document structures are complex, often non-structured text, containing extensive specialized terminology, abbreviations, and specific table formats. Fields and units involve dosage (mg/kg), concentration (µM), batch numbers, expiration dates, stability data, and detection limits (LOD/LOQ). These require extremely high precision and consistency.

Constraints on Multiturn Conversations and Prompts

The complexity of neurodegenerative disease quality documents imposes specific requirements on multiturn conversation and prompt design. Specialized terminology and abbreviations in documents require prompts to guide the model in understanding context. This prevents information bias from ambiguity. For example, references to "AD" (Alzheimer's Disease) or "PD" (Parkinson's Disease) require clear context. Multiturn conversations must handle long text and non-structured data. The model needs strong long-text comprehension to maintain topic coherence across multiple interactions. Document regulatory and rigorous nature means the model must strictly adhere to factual content from the source when generating responses. It must avoid speculation or generalization, especially for batch information, dosages, or regulatory clauses. Focus on precision and units requires prompts to specify desired information units or formats to ensure answer accuracy.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`maxContext`	`2000 characters`	Ensures context coherence in multiturn conversations, adapting to the density of specialized neurodegenerative document terminology.
`Chunk Length`	`500 characters`	Balances chunk granularity and semantic integrity, suitable for complex regulatory clauses and experimental descriptions.
`Recall Count`	`Top 8`	Ensures retrieval of sufficient key information related to neurodegenerative pathology and drug development from vast documents.
`Similarity Threshold`	`0.75`	Improves recall accuracy for highly specialized neurodegenerative documents with closely related vocabulary.
`Rerank Return Count`	`Top 3`	Further refines the most relevant document segments from high-similarity recalls, enhancing answer quality.
`TEMPERATURE`	`0.3`	Reduces randomness in model-generated responses, ensuring rigorous, fact-based output in quality document Q&A.

Common Mistakes

Dialog box error Cannot read properties of null (reading 'q'): This often occurs when prompts use undefined variables or fields, preventing the model from correctly parsing the query.
Model "forgets" or deviates from the topic in multiturn conversations: This happens when maxContext is set too low. It fails to retain enough context, causing the model to lose previous conversation background in subsequent turns.
Model responses contain generalized or imprecise dosage or batch information: This indicates that prompt design did not sufficiently emphasize strict adherence to original facts, or the TEMPERATURE parameter was set too high, increasing the model's freedom to generate content.

Verification

Conduct multiturn conversation tests. Ask questions involving neurodegenerative drug data from different batches and experimental stages. Check if the model maintains tracking and accurate citation of specific batch information throughout the conversation.
Use queries containing specific abbreviations (e.g., "ADME", "PK/PD"). Check if the model correctly understands their meaning in the neurodegenerative field and extracts information from relevant documents.
For specific units of measurement in documents (e.g., µg/mL, nM), ask if the model can precisely restate or calculate them. Check if the low randomness set by the TEMPERATURE parameter is reflected.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.